The accelerated aging model reveals critical mechanisms of late-onset Parkinson’s disease
暂无分享,去创建一个
Xianzheng Sha | Yin Wang | Yixue Li | Shiyan Li | Hongxin Liu | Shiyu Bian | Xianzheng Sha | Yin Wang | Hongxin Liu | Yixue Li | Shiyan Li | Shiyu Bian
[1] F. Sesti,et al. Oxidation of ion channels in the aging nervous system , 2016, Brain Research.
[2] Susan M. Resnick,et al. Morphometry of the human substantia nigra in ageing and Parkinson’s disease , 2008, Acta Neuropathologica.
[3] B. Cheeran,et al. Parkinson's Disease: New Insights into Pathophysiology and Rehabilitative Approaches , 2016, Parkinson's disease.
[4] H. Tian,et al. Transactivation of microRNA-383 by steroidogenic factor-1 promotes estradiol release from mouse ovarian granulosa cells by targeting RBMS1. , 2012, Molecular endocrinology.
[5] Y. Higami,et al. Apoptosis in the aging process , 2000, Cell and Tissue Research.
[6] Andrew J. Oler,et al. Bcl11b, a novel GATA3-interacting protein, suppresses Th1 while limiting Th2 cell differentiation , 2018, The Journal of experimental medicine.
[7] T. Wyss-Coray,et al. Systemic factors as mediators of brain homeostasis, ageing and neurodegeneration , 2020, Nature Reviews Neuroscience.
[8] I. Ekimova,et al. Parkinson’s Disease and Aging , 2019, Advances in Gerontology.
[9] Adducin family proteins possess different nuclear export potentials , 2017, Journal of Biomedical Science.
[10] J. Kordower,et al. Aging and Parkinson’s Disease: Different Sides of the Same Coin? , 2017, Movement disorders : official journal of the Movement Disorder Society.
[11] R. Takahashi,et al. ATP Maintenance via Two Types of ATP Regulators Mitigates Pathological Phenotypes in Mouse Models of Parkinson's Disease , 2017, EBioMedicine.
[12] S. Mallal,et al. T cells of Parkinson’s disease patients recognize α–synuclein peptides , 2017, Nature.
[13] M. Maggiolini,et al. The Physiopathological Role of the Exchangers Belonging to the SLC37 Family , 2018, Front. Chem..
[14] Salim Lahmiri,et al. Gait Nonlinear Patterns Related to Parkinson’s Disease and Age , 2019, IEEE Transactions on Instrumentation and Measurement.
[15] J. Fernández-Ruiz,et al. Development of An Oral Treatment with the PPAR-γ-Acting Cannabinoid VCE-003.2 Against the Inflammation-Driven Neuronal Deterioration in Experimental Parkinson’s Disease , 2019, Molecules.
[16] B. Liss,et al. Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's disease , 2016, Journal of neurochemistry.
[17] P. Aebischer,et al. Αlpha-Synuclein as a Mediator in the Interplay between Aging and Parkinson’s Disease , 2015, Biomolecules.
[18] M. Vila,et al. Autophagic- and Lysosomal-Related Biomarkers for Parkinson’s Disease: Lights and Shadows , 2019, Cells.
[19] Ryan J. Uitti,et al. Biomarkers in Parkinson's disease: Advances and strategies. , 2016, Parkinsonism & related disorders.
[20] PPARγ and PGC-1α as Therapeutic Targets in Parkinson’s , 2014, Neurochemical Research.
[21] C. Franceschi,et al. Aging and Parkinson's Disease: Inflammaging, neuroinflammation and biological remodeling as key factors in pathogenesis , 2018, Free radical biology & medicine.
[22] B. Brew,et al. Bcl11b—A Critical Neurodevelopmental Transcription Factor—Roles in Health and Disease , 2017, Front. Cell. Neurosci..
[23] B. Hayete,et al. Large-scale identification of clinical and genetic predictors of Parkinson’s disease motor progression in newly-diagnosed patients: a longitudinal cohort study and validation , 2017, The Lancet Neurology.
[24] S. Zanata,et al. PPAR-γ agonist pioglitazone reduces microglial proliferation and NF-κB activation in the substantia nigra in the 6-hydroxydopamine model of Parkinson’s disease , 2019, Pharmacological reports : PR.
[25] G. Halliday,et al. Inflammation is genetically implicated in Parkinson’s disease , 2015, Neuroscience.
[26] Robert Howard,et al. A novel multi-tissue RNA diagnostic of healthy ageing relates to cognitive health status , 2015, Genome Biology.
[27] J. Kirkland,et al. Cellular Senescence: A Translational Perspective , 2017, EBioMedicine.
[28] M. Mattson,et al. Brain metabolism in health, aging, and neurodegeneration , 2017, The EMBO journal.
[29] R. Thangavel,et al. Neuroinflammation Induces Neurodegeneration. , 2016, Journal of neurology, neurosurgery and spine.
[30] P. Rosenstiel,et al. Linear isoforms of the long noncoding RNA CDKN2B-AS1 regulate the c-myc-enhancer binding factor RBMS1 , 2018, European Journal of Human Genetics.
[31] S. Maier,et al. Aging-related changes in neuroimmune-endocrine function: Implications for hippocampal-dependent cognition , 2012, Hormones and Behavior.
[32] Amir Shmuel,et al. Performance of machine learning methods in diagnosing Parkinson’s disease based on dysphonia measures , 2017, Biomedical Engineering Letters.
[33] Ying Wang,et al. PPAR signaling pathway in the first trimester placenta from in vitro fertilization and embryo transfer. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[34] J. Błaszczyk. The Emerging Role of Energy Metabolism and Neuroprotective Strategies in Parkinson's Disease , 2018, Front. Aging Neurosci..
[35] T. Strom,et al. BCL11B mutations in patients affected by a neurodevelopmental disorder with reduced type 2 innate lymphoid cells , 2018, Brain : a journal of neurology.
[36] Linnan Zhu,et al. Impact of aging immune system on neurodegeneration and potential immunotherapies , 2017, Progress in Neurobiology.
[37] V. Kostulas,et al. Parkinson's disease and immunological abnormalities: increase of HLA‐DR expression on monocytes in cerebrospinal fluid and of CD45RO+ T cells in peripheral blood , 1994, Acta neurologica Scandinavica.
[38] V. Appay,et al. Aging of the immune system: Focus on inflammation and vaccination , 2016, European journal of immunology.
[39] M. Beal,et al. PPAR: a therapeutic target in Parkinson’s disease , 2008, Journal of neurochemistry.
[40] A. Abramov,et al. Mitochondrial calcium imbalance in Parkinson’s disease , 2017, Neuroscience Letters.
[41] A. Chawla,et al. BCL6 regulates brown adipocyte dormancy to maintain thermogenic reserve and fitness , 2019, Proceedings of the National Academy of Sciences.
[42] Amir Shmuel,et al. Detection of Parkinson's disease based on voice patterns ranking and optimized support vector machine , 2019, Biomed. Signal Process. Control..
[43] G. Leung,et al. A Review on Adducin from Functional to Pathological Mechanisms: Future Direction in Cancer , 2018, BioMed research international.
[44] M. Cano,et al. Advantages and disadvantages of apoptosis in the aging process , 2019, Annals of the New York Academy of Sciences.
[45] A. Carta. PPAR-γ: therapeutic prospects in Parkinson's disease. , 2013, Current drug targets.
[46] S. Mallal,et al. T cells of Parkinson’s disease patients recognize α–synuclein peptides , 2017, Nature.